Select Page

FAQ

If you have any questions or trouble accessing the conference, please feel free to call/text/email Amy Collier at 703-944-2828 or acollier@cjp.com.

Plenary Session and Break Links

**Green Room Link

MONDAY, AUGUST 10

SESSION 1: Next Generation in Genomics and Biomarkers

Plenary Session in Zoom (10:00am-12:15pm EDT)

Networking Session in Remo (12:15pm-1:30pm EDT)

SESSION 2: Next Generation in Bladder/Urothelial/Upper Tract and Renal Cancers

Plenary Session in Zoom (2:00pm-4:15pm EDT)

Networking Session in Remo (4:15pm-5:30pm EDT)

Virtual Cocktail Reception (5:30pm EDT)

SESSION 3: Next Generation Advanced and nmCRPC

Plenary Session in Zoom (6:00pm-8:20pm EDT)

Networking Session in Remo (8:20pm-9:30pm EDT)

TUESDAY, AUGUST 11

SESSION 4: Next Generation Imaging for Prostate Cancer

Plenary Session in Zoom (10:00am-12:00pm EDT)

Networking Session in Remo (12:00pm-1:15pm EDT)

SESSION 5: Next Generation Brachytherapy and Focal Therapy

Plenary Session in Zoom (2:00pm-4:00pm EDT)

Networking Session in Remo (4:05pm-5:30pm EDT)

SESSION 6: Next Generation Consensus Development Panels for Publishing in Grand Rounds in Urology

Plenary Session in Zoom (6:00pm-7:45pm EDT)

Plenary Session Dial-In Information

One tap mobile
+13126266799,,6979888394# US (Chicago)
+16465588656,,6979888394# US (New York)

Dial by your location
+1 312 626 6799 US (Chicago)
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Germantown)
+1 346 248 7799 US (Houston)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)

Meeting ID: 697 988 8394

Find your local number:
https://us02web.zoom.us/u/keETr1B27T

Agenda

Join us for the full virtual FDUS conference on Monday, August 10th and Tuesday, August 11th.

ALL TIMES EASTERN TIME

Monday, August 10, 2020

10:00am-10:10am

Welcome/Overview of FDUS Think Tank
Presented by Grand Rounds in Urology
Program Director: E. David Crawford, MD

10:10am-12:15pm

Session 1: Next Generation in Genomics and Biomarkers
Leonard G. Gomella, MD, FACS – Moderator

Discussants:
Gerald L. Andriole, Jr., MD
Alan H. Bryce, MD
Brian F. Chapin, MD
David Crawford, MD
Steven E. Finkelstein, MD, FACRO
Karim Kader, MD, PhD
Neal D. Shore, MD, FACS

10:10am-10:15am
Moderator and Poll Questions

10:15am-10:20am

Gerald L. Andriole, MD – Updates in Screening Prostate Cancer Guidelines

10:20am-10:25am

E. David Crawford, MD – PC Markers Algorithm

10:25am-10:30am

Alan H. Bryce, MD – Genetics in Biomarkers for Prostate Cancer and Bladder Cancer

10:30am-11:15am

Panel Discussion

11:15am-12:15pm

State-of-the-Art 10-Minute Presentations from Industry Partners

11:15am-11:25pm

Exact Sciences – Brian T. Helfand, MD

11:30am-11:40pm

MDxHealth – Ericka Bagi, RN

11:40am-12:10pm

Additional Discussion and Q&A

12:15pm-1:30pm

Pre-Scheduled Breakout Sessions in Networking Suites

1:30pm-2:00pm

Break

2:00pm-4:15pm

Session 2: Next Generation in Bladder/Urothelial/Upper Tract  Cancers
Sia Daneshmand, MD – Moderator

Discussants:
Gordon A. Brown, DO
Robert Dreicer, MD, MS, MACP, FASCO
Leonard G. Gomella, MD, FACS
Ashish M. Kamat, MD, MBBS
Thomas E. Keane, MD
Seth P. Lerner, MD
Benjamin H. Lowentritt, MD, FACS
Daniel P. Petrylak, MD
Neal D. Shore, MD, FACS

2:00pm-2:05pm

Moderator Introduction and Poll Questions

2:05pm-2:10pm

Sia Daneshmand, MD – Updates in Muscle Invasive Bladder Cancer

2:10pm-2:15pm

Ashish M. Kamat, MD, MBBS – Updates in Non-Muscle Invasive Bladder Cancer

2:15pm-2:20pm

Seth P. Lerner, MD – Updates in Upper Tract Urothelial Cancer

2:20pm-3:15pm

Panel Discussions

3:15pm-4:15pm

State-of-the-Art 10-Minute Presentations from Industry Partners

  • Urothelial/Bladder Cancer
  • UTUC

3:15pm-3:25pm

UroGen Pharma – Sandip M. Prasad, MD

3:25pm-4:10pm

Additional Discussion and Q&A

4:15pm-5:30pm

Pre-Scheduled Breakout Sessions in Networking Suites

5:30pm-6:00pm

Virtual Cocktail Reception for Faculty and Sponsors

6:00pm-8:20pm

Session 3: Next Generation Advanced and nmCRPC
Neal D. Shore, MD, FACS – Moderator 

Discussants:
Gordon A. Brown, DO
Alan H. Bryce, MD
Brian F. Chapin, MD
David Crawford, MD
Robert Dreicer, MD, MS, MACP, FASCO
Marc B. Garnick, MD
Leonard G. Gomella, MD, FACS
Jason M. Hafron, MD
Celestia S. Higano, MD, FACP
Christopher J. Kane, MD, FACS
Thomas E. Keane, MD
Gary M. Onik, MD
Daniel P. Petrylak, MD
Clifton Vestal, MD

6:00pm-6:05pm

Moderator Introduction and Poll Questions

6:05pm-6:10pm

Alan H. Bryce, MD – Updates in PARP Inhibition and Germline Testing

6:10pm-6:15pm

Celestia S. Higano, MD, FACP – Updates in ADT and nmCRPC

6:15pm-6:25pm

Gary M. Onik, MD – In situ Tumor Vaccine in Treating Metastatic Prostate Cancer

6:25pm-7:20pm

Panel Discussion

7:20pm-8:20pm

State-of-the-Art 10-Minute Presentations from Industry Partners

7:20pm-7:30pm

Janssen Biotech – Daniel Santos, MBA

7:30pm-7:40pm

AstraZeneca – Jennifer Jordan, PhD

7:40pm-7:50pm

Tolmar Pharmaceuticals – Stuart Atkinson, MD

7:50pm-8:00pm

Myovant Sciences – Video presentation by Neal D. Shore, MD

8:00pm-8:10pm

Amgen – Bela S. Denes, MD

8:10pm-8:20pm

Sun Pharma – Nicholas Squittieri, MD

8:20pm-9:30pm

Pre-Scheduled Breakout Sessions in Networking Suites

Adjourn

Tuesday, August 11, 2020

10:00am-12:00pm

Session 4: Next Generation Imaging for Prostate Cancer
Gerald L. Andriole, Jr. – Moderator

Discussants:
Brian F. Chapin, MD
David Crawford, MD
John W. Davis, MD
Steven E. Finkelstein, MD, FACRO
Phillip J. Koo, MD
Neal D. Shore, MD, FACS

10:00am-10:05am

Moderator Introduction and Poll Questions

10:05am-10:10am

John W. Davis, MD – Updates in mpMRI

10:10am-10:15am

Gerald L. Andriole, Jr., MD – Updates in PSMA

10:15am-10:20am

Philip J. Koo, MD – Imaging Advances from the Radiologist Perspective

10:20am -11:20am

Panel Discussion

11:20am-12:00pm

State-of-the-Art 10-Minute Presentations from Industry Partners

11:20am-11:30pm

Blue Earth Diagnostics – Phillip Davis, MD

11:30am-12:00pm

Additional Discussion and Q&A

12:00pm-1:15pm

Pre-Scheduled Breakout Sessions in Networking Suites

1:15pm-2:00pm

Break

2:00pm-4:00pm

Session 5: Next Generation Brachytherapy and Focal Therapy
E. David Crawford, MD – Moderator

Discussants:
Brian F. Chapin, MD
Steven E. Finkelstein, MD, FACRO
Marc B. Garnick, MD
Gary M. Onik, MD
Thomas J. Polascik, MD, FACS

2:00pm-2:05pm

Moderator Introduction and Poll Questions

2:05pm-2:10pm

John W. Davis – Updates in Surgical Approaches to PCa: What’s New from the AUA?

2:10pm-2:15pm

Thomas J. Polascik, MD, FACS – Updates in Focal Therapy

2:15pm-2:20pm

Steven E. Finkelstein, MD, FACRO – Updates in Brachytherapy

2:20pm-3:00pm

Panel Discussion

3:00pm-4:00pm

State-of-the-Art 10-Minute Presentations from Industry Partners

  • Brachytherapy/Focal Therapy

4:00pm-5:30pm

Pre-Scheduled Breakout Sessions in Networking Suites

5:30pm-6:00pm

Break

6:00pm-7:45pm

Session 6: Next Generation Consensus Development Panels for Publishing in Grand Rounds in Urology
David Crawford, MD – Moderator

6:00pm-6:20pm

S1 – Genomics and Biomarkers Panel Discussion
Moderators: Gomella and Bryce

6:20pm-6:40pm

S2 – GU Cancers Panel Discussion
Moderators: Daneshmand and Lerner

6:40pm-7:00pm

S3 – CRPC Panel Discussion
Moderators: Shore and Petrylak

7:00pm-7:20pm

S4 – Next Generation Imaging Panel Discussion
Moderators: Andriole and Koo

7:20pm-7:40pm

S4 – Next Generation Imaging Panel Discussion
Moderators: Crawford and Finkelstein

7:40pm-7:45pm

Wrap-up/Final Comments of FDUS Think Tank
Program Director: E. David Crawford, MD

7:45pm

Adjourn

Faculty

Gerald L. Andriole, Jr., MD

Gerald L. Andriole, Jr., MD

Washington University
St. Louis, Missouri
Alan H. Bryce, MD

Alan H. Bryce, MD

Mayo Clinic
Scottsdale, Arizona
Gordon A. Brown, DO

Gordon A. Brown, DO

New Jersey Urology
Cherry Hill, New Jersey
Brian F. Chapin, MD

Brian F. Chapin, MD

UT MD Anderson Cancer Center
Houston, Texas
Edward S. Cohen, MD

Edward S. Cohen, MD

Genesis Healthcare
San Diego, California
E. David Crawford, MD

E. David Crawford, MD

PROGRAM DIRECTOR

University of California, San Diego
San Diego, California

Siamak Daneshmand, MD

Siamak Daneshmand, MD

Keck School of Medicine at USC
Los Angeles, California
Robert Dreicer, MD, MS, MACP, FACRO

Robert Dreicer, MD, MS, MACP, FACRO

University of Virginia
Charlottesville, VA
Steven E. Finkelstein, MD, FACRO

Steven E. Finkelstein, MD, FACRO

Florida Cancer Affiliates
Panama City Beach, Florida
Marc B. Garnick, MD

Marc B. Garnick, MD

Harvard Medical School
Boston, Massachusetts
Leonard G. Gomella, MD, FACS

Leonard G. Gomella, MD, FACS

Thomas Jefferson University
Philadelphia, Pennsylvania
Jason M. Hafron, MD

Jason M. Hafron, MD

Michigan Institute of Urology
West Bloomfield, Michigan
Celestia S. Higano, MD, FACP

Celestia S. Higano, MD, FACP

University of Washington
Seattle, Washington
A. Karim Kader, MD, PhD

A. Karim Kader, MD, PhD

University of California, San Diego
San Diego, California
Ashish M. Kamat, MD, MBBS

Ashish M. Kamat, MD, MBBS

UT MD Anderson Cancer Center
Houston, Texas
Christopher J. Kane, MD, FACS

Christopher J. Kane, MD, FACS

University of California, San Diego
San Diego, California
Thomas E. Keane, MD

Thomas E. Keane, MD

Medical University of South Carolina
Charleston, South Carolina
Phillip J. Koo, MD

Phillip J. Koo, MD

Banner MD Anderson Cancer Center
Phoenix, Arizona
Seth P. Lerner, MD

Seth P. Lerner, MD

Baylor College of Medicine
Houston Texas
Daniel W. Lin, MD

Daniel W. Lin, MD

University of Washington
Seattle, Washington
Benjamin H. Lowentritt, MD, FACS

Benjamin H. Lowentritt, MD, FACS

Chesapeake Urology
Towson, Maryland
Gary M. Onik, MD

Gary M. Onik, MD

Diagnostic Radiology Specialist
Celebration, Florida
Daniel P. Petrylak, MD

Daniel P. Petrylak, MD

Yale Cancer Center
New Haven, Connecticut
Eugene Y. Rhee, MD, MBA

Eugene Y. Rhee, MD, MBA

Kaiser Permanente
San Diego, California
Neal D. Shore, MD, FACS

Neal D. Shore, MD, FACS

Atlantic Urology Clinics
Myrtle Beach, South Carolina
J. Clifton Vestal, MD

J. Clifton Vestal, MD

Urology Associates of North Texas/USMD
Arlington, Texas

Participants

Stuart Atkinson, MB, ChB
Vice President, Head Medical Affairs
Tolmar

Ericka Bagi, RN
MDxHealth

Michael Bokor
Assistant Director
Astellas Pharma US

Jessica Castle, PhD
Principal Regional Medical Advisor
Myovant

Alain Chaglassian, MD
Medical Science Liaison Northeast
Blue Earth Diagnostics

Phillip Davis, MD
Vice President, Clinical Science and Regulatory Strategy (US)
Blue Earth Diagnostics

Bela Denes, MD
Global Medical Affairs Lead – Urology
Amgen

Mary Fridman
Medical Science Liaison
UroGen Pharma

Caitlin Hawthorne
Senior Marketing Manager Oncology XTANDI
Astellas Pharma US

Jennifer Hayes, PhD
Director, Medical Alignment, US Medical Affairs – Oncology
AstraZeneca

Chris Hewitt
Director, Oncology Regional Marketing – Prostate Franchise
Bayer

Dan Hogan
Director, Marketing Innovation
Tolmar

Tara Janowski
Associate Director, Field Marketing
Clovis Oncology

Jennifer Jordan, PhD
Medical Science Liaison, Oncology
AstraZeneca

Ken Kami
Vice President, Marketing
MDxHealth

Bryce Kanter, MBA, MS
Director of US Marketing, Prostate Cancer
Advanced Accelerator Applications,
a Novartis company

Hosein Kouros-Mehr, MD
Medical Director
Amgen

Jina Lee, PharmD
Director, Medical Affairs Strategy – Prostate Cancer
Myovant

Jennifer Lee
Brand Manager, Oncology
Sun Pharma

Michael Massello
Lynparza Regional Marketing Lead
AstraZeneca

Tracy McGowan, MD
Senior Medical Director, Therapeutic Area Lead/Oncology/Medical Affairs
Janssen

Tim Mikhelashvili
Director, Medical Science Liaison
UroGen Pharma

Sherri Moroni, RN
Associate Director, Regional Marketing, Prostate Cancer
Advanced Accelerator Applications,
a Novartis company

Mitch Nagao, PharmD, MBA
Vice President, Medical Affairs Strategy
Myovant

Andrew Park
Director, Marketing
Clovis Oncology

Camille Pope, PharmD
Oncology Medical Director, DNA Damage Response (DDR) LCM
AstraZeneca

Rushi Potdar, MD
Director, Medical Affairs
Janssen

Glenn Ravelo
Associate Vice President, Oncology Sales
Sun Pharma

Jacqueline Reilly
Associate Medical Director
Janssen

Virginia Rhodes, MD
Medical Science Liaison
UroGen Pharma

Michael Ryan, PharmD, RPh
Regional Medical Advisor
Myovant

Vivek Saini
National Opinion Leader Liaison, US Prostate Cancer, Xtandi Marketing
Pfizer Oncology

Mark Salvati, PhD
Global Product General Manager, Oncology Early Development Lead
Amgen

Daniel Santos
US Group Product Director Oncology
Janssen

Brent Schneider
Associate Director, HCP Marketing Lead
Clovis Oncology

Mark Schoenberg, MD
Chief Medical Officer
UroGen Pharma

Bob Siegwarth
Sr. Regional Sales Director
Tolmar

Kristen Slangerup, PhD
Director of Medical Alignment DNA Oncology Medical Science Liaison
AstraZeneca

Pam Sperl, PharmD
Senior Director, Field Medical
Myovant

Ben Thomas
Director, Corporate Accounts
Tolmar

Rosie Xie, PhD
Regional Medical Advisor
Myovant

Rolanso Zeron
Director, Marketing
Clovis Oncology